A phase 3, double blind , multicenter trial comparing tegoprazan 25 mg with lansoprazole 15 mg as maintenance therapy in healed erosive oesophagitis
Latest Information Update: 03 Nov 2022
Price :
$35 *
At a glance
- Drugs Lansoprazole (Primary) ; Tegoprazan (Primary)
- Indications Erosive oesophagitis
- Focus Therapeutic Use
- 03 Nov 2022 New trial record
- 31 Oct 2022 Results published in the Alimentary Pharmacology and Therapeutics
- 11 Oct 2022 Post hoc analysis assessing to compare tegoprazan 25 mg to lansoprazole 15 mg as maintenance therapy in healed erosive esophagitis presented at the 30th United European Gastroenterology Week